Corcept Therapeutics Inc.
€62.6
EUR
Last updated on --.
24h volume510.00
24h highest62.9881 EUR
24h lowest59.9554 EUR
24h Price movement-0.01%
CORT recent prices
24 Hours
-0.01%-€0.008618
30 days
+41.52%+€18.36
60 days
+77.82%+€27.39
90 days
+114.47%+€33.41
Key data
Previous close62.6098 EUR
Market cap6.43B EUR
Volume510.00
P/E ratio161.770000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.37057 EUR
Net income (FY)40.80M EUR
Revenue (FY)662.81M EUR
Last report dateApr 30, 2026
About Corcept Therapeutics Inc.
HeadquartersREDWOOD CITY
Employees (FY)730.00
Revenue per employee (FY)907.95K EUR
Net income per employee (FY)55.89K EUR
Listed onNasdaq
CORT conversion tables
 |  |
|---|---|
| 0.5 CORT | 31.3 EUR |
| 1 CORT | 62.6 EUR |
| 5 CORT | 313 EUR |
| 10 CORT | 626.01 EUR |
| |
|---|---|
| 0.5 EUR | 0.0079871 CORT |
| 1 EUR | 0.015974 CORT |
| 5 EUR | 0.079871 CORT |
| 10 EUR | 0.15974 CORT |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CORT is trading at €62.60, -0.01% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CORT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CORT is currently trading at €62.60, -0.01% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CORT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CORT's P/E ratio is currently 161.770000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CORT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CORT's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Corcept Therapeutics Inc.'s market cap is currently 6.43B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume510.00
24h highest62.9881 EUR
24h lowest59.9554 EUR
24h Price movement-0.01%
Start trade with CORT Perpetual
Sign up to trade